Omalizumab for severe asthma: toward personalized treatment based on biomarker profile and clinical history
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Asthma and Allergy"
DOI: 10.2147/jaa.s107982
Abstract: Asthma is a heterogeneous syndrome with numerous underlining molecular and inflammatory mechanisms contributing to the wide spectrum of clinical phenotypes. Multiple therapies targeting severe asthma with type 2 (T2) high inflammation are or soon will… read more here.
Keywords: clinical history; omalizumab severe; severe asthma; asthma toward ... See more keywords